Sort
82,697 grants matching “vaccine development”
Contributions of durable, high-avidity T-cell responses to protection achieved using the Opti-FliP vaccine regimen
$1,260,330Dennis J Hartigan-O'Connor · University Of California At Davis · P01 · FY2025 · AI
Dynamics of Protein Assemblies by Analytical Ultracentrifugation
$1,260,310Peter Schuck · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2023 · EB
Non-Human Primate Core (NHP Core)
$1,260,301Koen K Van Rompay · Duke University · P01 · FY2016 · AI
Antiviral therapeutics for flavivirus infections
$1,260,044Chelsea Byrd Olsen · Siga Technologies, Inc. · R01 · FY2012 · AI
Multicenter AIDS Cohort Study
$1,260,025Charles R Rinaldo · University Of Pittsburgh At Pittsburgh · U01 · FY2009 · AI
University of California, Berkeley (UCB)/University of *
$1,260,000Arthur L. Reingold · University Of California Berkeley · D43 · FY2006 · TW
Response Therapies for MDR-TB
$1,259,826Ian M Orme · Colorado State University · U01 · FY2010 · AI
Developing an inactivated whole cell H. pylori vaccine
$1,259,746Emergent Biosolutions · U01 · FY2005 · AI
Aurum Clinical Trials Unit
$1,258,716Gavin John Churchyard · Aurum Institute Npc · UM1 · FY2022 · AI
CTL and HIV Polymorphisms in Heterosexual Transmission
$1,258,577Eric Hunter · Emory University · R01 · FY2006 · AI
High Precision System Analysis of Infant Immune Responses
$1,258,393Pablo J. Sanchez · Research Inst Nationwide Children'S Hosp · U01 · FY2021 · AI
Laboratory Studies of Human Respiratory Syncytial Virus and Other Pneumoviruses
$1,258,386Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Clinical Trials of Vaccines for Respiratory Syncytial Virus and Related Viruses
$1,258,384Ursula Buchholz · National Institute Of Allergy And Infectious Diseases · ZIA · FY2020 · AI
Vaccines to counter emerging antibiotic resistance (R01AI138970)
$1,258,174Wendy L Picking · University Of Missouri-Columbia · R01 · FY2022 · AI
Stimulant Pharmacotherapy: Noradrenergic Targets
$1,257,829Thomas Richard Kosten · Baylor College Of Medicine · P50 · FY2012 · DA
Computational biology scientific research support component
$1,257,775Thomas B Kepler · Duke University · UM1 · FY2018 · AI
Human Monoclonal Antibodies and Antibody-Guided Nanoparticles
$1,257,527Dimiter S Dimitrov · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
UCSF-Stanford Center of Excellence in Regulatory Science and Innovation
$1,257,392Kathleen M Giacomini · University Of California, San Francisco · U01 · FY2024 · FD
St. Jude/Memphis IMPAACT Clinical Trials Unit
$1,257,366Patricia Michele Flynn · St. Jude Children'S Research Hospital · U01 · FY2007 · AI
Harnessing B cells for TB vaccine development to improve therapy of TB and TB-HIV coinfection
$1,257,077Martin Alfons Gengenbacher · Hackensack University Medical Center · R01 · FY2025 · AI
Recombinant Vaccines for Prevention of AIDS and Other Diseases
$1,256,929Bernard Moss · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
SPORE in Skin Cancer
$1,256,837Wistar Institute · P50 · FY2001 · CA
CTSA INFRASTRUCTURE FOR AIDS RESEARCH
$1,256,490Barry Coller · Rockefeller University · UL1 · FY2007 · RR
Synthesis of Therapeutic Agents for Treatment of Infectious Diseases
$1,256,450Mark Middleton · Starks Associates, Inc. · N01 · FY2021 · AI
Cervical, Anal & Oral HPV Persistence/Adolescent Girls
$1,256,429Angela Diaz · Icahn School Of Medicine At Mount Sinai · R01 · FY2023 · AI